智通财经获悉,GE HealthCare (GEHC.US)已同意从Sumitomo Chemical手中收购Nihon Medi-Physics (NMP)剩余50%的股份,旨在获得这家日本放射性制药公司的完全所有权。该公司预计该交易将于2025年初完成。该交易预计将对GE HealthCare第一年的调整后每股收益产生中性影响,此后将增加收益。
NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...
Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...
智通财经获悉,GE HealthCare(GEHC.US)已同意从Sumitomo Chemical手中收购Nihon ...
Sumitomo Chemical Co (JP:4005) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...
GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, ...
GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...
Sharekhan is bullish on Sumitomo Chemical India has recommended buy rating on the stock with a target price of Rs 659 in its research report dated October 29, 2024. Buy Sumitomo Chemical India ...
GE HealthCare to buy remaining 50% stake in Japanese radiopharmaceutical company, Nihon Medi-Physics from Sumitomo Chemical: Chalfont St Giles, UK Monday, December 2, 2024, 14:00 ...